Subsidiary of Hainan Huluwa Pharmaceutical Group (605199.SH) obtains registration certificate for potassium chloride oral solution drug.
ST Huluo Dolls (605199.SH) announced that its wholly-owned subsidiary Guangxi Weiwei Pharmaceutical Co., Ltd. (referred to as "Guangxi Weiwei") recently received the "Drug Registration Certificate" for potassium chloride oral solution issued by the National Medical Products Administration.
Hainan Huluwa Pharmaceutical Group (605199.SH) announced that its wholly-owned subsidiary Guangxi Weiwei Pharmaceutical Co., Ltd. (referred to as "Guangxi Weiwei") recently received the "Drug Registration Certificate" approved and issued by the National Medical Products Administration for potassium chloride oral solution.
Potassium chloride oral solution is used to treat and prevent hypokalemia with or without metabolic alkalosis. It is used in patients where dietary management with potassium-rich foods or reduction of diuretic doses is ineffective.
Related Articles
JD LOGISTICS (02618) spent 24.59 million Hong Kong dollars to repurchase 1.8503 million shares on June 1st.
Shenwan Hongyuan Group (06806): "26 application letter 05" and "26 application letter 06" will be listed on the Shenzhen Stock Exchange starting from June 1st.
Niche-Tech Semi(08490): Shi Yiwu resigns as executive director.
JD LOGISTICS (02618) spent 24.59 million Hong Kong dollars to repurchase 1.8503 million shares on June 1st.
Shenwan Hongyuan Group (06806): "26 application letter 05" and "26 application letter 06" will be listed on the Shenzhen Stock Exchange starting from June 1st.
Niche-Tech Semi(08490): Shi Yiwu resigns as executive director.
